IRIS
PICARDI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.695
NA - Nord America 2.040
EU - Europa 942
SA - Sud America 436
AF - Africa 56
OC - Oceania 28
Totale 16.197
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 10.265
US - Stati Uniti d'America 1.922
CN - Cina 1.212
HK - Hong Kong 786
BR - Brasile 333
GB - Regno Unito 252
VN - Vietnam 218
IT - Italia 202
DE - Germania 150
CA - Canada 68
IN - India 60
FI - Finlandia 59
NL - Olanda 48
AR - Argentina 42
PL - Polonia 38
MX - Messico 33
TR - Turchia 32
FR - Francia 29
ES - Italia 27
ID - Indonesia 27
ZA - Sudafrica 27
AU - Australia 26
CZ - Repubblica Ceca 25
EC - Ecuador 24
RU - Federazione Russa 24
UA - Ucraina 22
JP - Giappone 16
CH - Svizzera 11
CL - Cile 10
SE - Svezia 9
BD - Bangladesh 8
CO - Colombia 8
SA - Arabia Saudita 7
BE - Belgio 6
PY - Paraguay 6
AT - Austria 5
BY - Bielorussia 5
DK - Danimarca 5
LT - Lituania 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
DO - Repubblica Dominicana 4
IQ - Iraq 4
MA - Marocco 4
MY - Malesia 4
PE - Perù 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BH - Bahrain 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
IR - Iran 3
LB - Libano 3
OM - Oman 3
TH - Thailandia 3
UZ - Uzbekistan 3
AM - Armenia 2
AO - Angola 2
CM - Camerun 2
EE - Estonia 2
GT - Guatemala 2
HT - Haiti 2
HU - Ungheria 2
IE - Irlanda 2
IS - Islanda 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
MW - Malawi 2
PK - Pakistan 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TL - Timor Orientale 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GN - Guinea 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
ML - Mali 1
MS - Montserrat 1
Totale 16.183
Salva come PNG Salva come JPEG
Città #
Singapore 771
Hong Kong 769
Hefei 494
Ashburn 451
Boardman 264
Beijing 237
Dallas 221
London 203
Shanghai 190
Munich 87
Ho Chi Minh City 86
Rome 82
Los Angeles 74
Council Bluffs 69
San Francisco 61
São Paulo 41
West Jordan 41
Seattle 39
Hanoi 38
Toronto 38
Turku 38
Warsaw 36
Santa Clara 34
Pune 32
Washington 31
Amsterdam 27
New York 25
Brno 22
Mexico City 22
Helsinki 21
Sona 20
Brooklyn 19
Boston 17
Montreal 16
Rio de Janeiro 15
Atlanta 13
Johannesburg 13
Tokyo 13
Guangzhou 12
Haiphong 12
Brasília 11
Central 11
Da Nang 11
Manchester 11
Melbourne 11
Chennai 10
Chicago 10
Paris 10
Canberra 9
Guayaquil 9
Milan 9
Thái Bình 9
Charlotte 8
Stockholm 8
Curitiba 7
Ankara 6
Frankfurt am Main 6
Haikou 6
Moscow 6
Redmond 6
Riyadh 6
Belo Horizonte 5
Hải Dương 5
Jinan 5
Poplar 5
Quito 5
Secaucus 5
Thái Nguyên 5
Zhengzhou 5
Berlin 4
Buenos Aires 4
Bắc Giang 4
Campinas 4
Copenhagen 4
Delhi 4
Denver 4
Hanover 4
Naples 4
Ninh Bình 4
Phoenix 4
Porto Alegre 4
Salvador 4
Sydney 4
The Dalles 4
Vienna 4
Xingtai 4
Bangkok 3
Barra Mansa 3
Biên Hòa 3
Bologna 3
Brownsville 3
Buffalo 3
Camden 3
Cao Lanh 3
Chengdu 3
Durban 3
Guarulhos 3
Ha Long 3
Handan 3
Hưng Yên 3
Totale 5.024
Salva come PNG Salva come JPEG
Nome #
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 225
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 207
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 206
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 202
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 201
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 199
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 199
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 199
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 198
[Consensus interferon: a new weapon in the treatment of chronic hepatitis C] 195
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 195
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 194
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 194
[Protective effect of verapamil in myocardial hypertrophy due to aortic stenosis experimentally induced in the rat] 194
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 194
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 193
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 191
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 190
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 189
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 189
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 189
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 188
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 182
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 181
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 181
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 180
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 179
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 179
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 178
Assessment of liver function by the exhaled breath-print during chronic liver disease 177
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 175
Blood glucose monitoring in the normal population: the PREDICA study 172
Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon 172
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 169
[Hepatocarcinoma: from epidemiology to gene therapy] 169
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 164
ALEX (R) (artificial liver for extracorporeal xenoassistance): A new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model 160
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 135
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 112
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 110
GH-resistance in different stages of chronic liver disease 109
Diabetes in chronic liver disease: from old concepts to new evidence 107
Enhanced portal flow velocity and volume following Iloprost treatment 104
Anestesia e malattie non comuni 104
Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes 104
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 103
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 100
[A 73-year-old woman with vomiting and metabolic alkalosis] 100
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 99
Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I 98
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 98
Radiofrequency ablation of hepatic tissue: a new experimental animal model 97
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 95
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 95
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 95
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 95
A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats 95
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 94
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 94
A challenging alfa-fetoprotein in a cirrhotic patient 92
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 92
Anesthesia & uncommon diseases 91
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 90
[A 74-year-old woman with macrocytic anemia] 90
Breathprinting of liver diseases 89
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 88
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 88
[A 61-year-old woman with abdominal pain and urination disorders] 88
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 88
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 88
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 87
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 86
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 82
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 82
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 82
Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support 82
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 82
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies: Haploidentical vs HLA Identical Transplantation in Hematologic Malignancies 82
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 81
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 80
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 80
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 78
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 78
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 75
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 74
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 73
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 70
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 68
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 65
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 64
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 60
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 58
The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population 55
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 54
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 50
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 49
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 49
Pain and Frailty in Hospitalized Older Adults 48
Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia 47
Reelin expression in human liver of patients with chronic hepatitis C infection 46
Totale 12.243
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.535
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022394 0 2 9 0 3 3 4 5 35 10 5 318
2022/2023118 21 1 3 5 5 5 15 4 3 8 45 3
2023/2024824 51 54 25 78 77 333 3 37 13 76 28 49
2024/202512.233 146 74 306 50 192 279 163 39 646 801 4.413 5.124
2025/20262.700 773 390 548 874 115 0 0 0 0 0 0 0
Totale 16.269